CHPA Takes Position on Methamphetamine Problem

JANUARY 01, 2005

The President of the Consumer Healthcare Products Association (CHPA) is advocating for a comprehensive methamphetamine solution. CHPA President Linda A. Suydam, DPA, recently testified before the US House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources.

Although pseudoephedrine is a nonprescription nasal decongestant used safely and effectively to treat cold, allergy, and flu symptoms, Suydam noted the industry's strong concern that the ingredient can be illegally obtained and used with other products to manufacture the illegal drug methamphetamine. At the hearing entitled "Law Enforcement and the Fight Against Methamphetamine," Suydam recommended the following:

  • Limit the number of packages of medicines with pseudoephedrine a consumer can purchase at a time
  • Require registration of all retailers selling pseudoephedrine products
  • Enact severe penalties for those manufacturing and selling methamphetamine, especially those endangering children with illegal activities


SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

Pharmacy Times Strategic Alliance
 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.